Principal Financial Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.02M | Buy |
|
|||||
|
2025
Q2 | $3.83M | Sell |
|
|||||
|
2025
Q1 | $15.6M | Sell |
|
|||||
|
2024
Q4 | $34.3M | Buy |
|
|||||
|
2024
Q3 | $33.4M | Sell |
|
|||||
|
2024
Q2 | $57.4M | Buy |
|
|||||
|
2024
Q1 | $5.92M | Sell |
|
|||||
|
2023
Q4 | $4.78M | Buy |
|
|||||
|
2023
Q3 | $2.67M | Buy |
|
|||||
|
2023
Q2 | $2.43M | Buy |
|
|||||
|
2023
Q1 | $2.9M | Sell |
|
|||||
|
2022
Q4 | $3.03M | Buy |
|
|||||
|
2022
Q3 | $2.2M | Sell |
|
|||||
|
2022
Q2 | $1.6M | Buy |
|
|||||
|
2022
Q1 | $1.36M | Sell |
|
|||||
|
2021
Q4 | $1.68M | Sell |
|
|||||
|
2021
Q3 | $2.2M | Sell |
|
|||||
|
2021
Q2 | $2.08M | Sell |
|
|||||
|
2021
Q1 | $2M | Buy |
|
|||||
|
2020
Q4 | $4.32M | Buy |
|
|||||
|
2020
Q3 | $3.53M | Sell |
|
|||||
|
2020
Q2 | $4.37M | Buy |
|
|||||
|
2020
Q1 | $1.9M | Buy |
|
|||||
|
2019
Q4 | $2.41M | Sell |
|
|||||
|
2019
Q3 | $1.42M | Sell |
|
|||||
|
2019
Q2 | $3.27M | Buy |
|
|||||
|
2019
Q1 | $2.41M | Buy |
|
|||||
|
2018
Q4 | $1.89M | Sell |
|
|||||
|
2018
Q3 | $3.12M | Buy |
|
|||||
|
2018
Q2 | $2.45M | Sell |
|
|||||
|
2018
Q1 | $1.48M | Buy |
|
|||||
|
2017
Q4 | $1.08M | Buy |
|
|||||
|
2017
Q3 | $402K | Sell |
|
|||||
|
2017
Q2 | $310K | Sell |
|
|||||
|
2017
Q1 | $280K | Buy |
|
|||||
|
2016
Q4 | $256K | Buy |
|
|||||
|
2016
Q3 | $467K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $298K | Buy |
|
|||||
|
2015
Q3 | $225K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $166K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $252K | Sell |
|
|||||
|
2014
Q1 | $250K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $470K | Sell |
|
|||||
|
2013
Q2 | $403K | Buy |
|